In 2015, more than 30,000 Americans died from overdosing on opioids, and a new study led by the University of Georgia shows that one of the hardest hit populations-low-income Americans on Medicaid-isn't getting the help it ...
Mar 30, 2017
1
0
While there are highly effective treatments for the hepatitis C virus (HCV), only one in five Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell ...
Aug 10, 2023
0
1
More than half of all Medicaid enrollees prefer the "one-stop shop" of a hospital emergency department to receive care for conditions that could be treated effectively at a primary care clinic, according to an article by ...
May 14, 2015
0
11
The first peer-reviewed comprehensive analysis of the effects of Medicaid expansion paints a picture of significant improvements in various health outcomes consistent with the original goals of the Affordable Care Act, also ...
Jun 5, 2018
0
3
The cost of expanding Medicaid under President Barack Obama's health care overhaul is rising faster than expected in many states, causing budget anxieties and political misgivings.
Oct 5, 2016
0
0
The state of Michigan has agreed to settle a class-action lawsuit over a policy that restricts certain hepatitis C treatments in the Medicaid program.
Mar 14, 2018
0
4
Oregon Medicaid enrollees are less likely to make unscheduled trips to the hospital following the implementation of the state's accountable-care model, new research by Oregon State University shows.
Oct 7, 2019
0
0
(HealthDay)—Medicaid work requirements will only impact a small proportion of persons and may only generate minimal savings, according to two research letters published online Sept. 10 in JAMA Internal Medicine.
Sep 11, 2018
0
0
A new study into the race and socio-demographics of newborns with symptoms of opioid withdrawal shows that it is disproportionately higher among white newborns whose mothers are Medicaid enrollees and have the lowest income, ...
Jul 31, 2023
0
19
Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in JAMA Network Open.
May 30, 2024
0
0
